The rate of people who can't afford needed health care is at the lowest rate in 16 years.» Read More
The agency approved the powerful painkiller OxyContin for a new use in children 11 to 16 who are suffering from severe, long-term pain.
The Royal Society for Public Health has called on the government to introduce a "smoking exclusion zone around pubs, bars and schools."
A freak snow storm in November has triggered a mini baby boom in Upstate New York, according to NBC News in New York.
Brace yourself for some big changes in 2018 if the so-called Obamacare Cadillac tax isn't changed.
The FDA issued a warning letter to a pharmaceutical company after Kim Kardashian posted a promotional selfie with one of its drugs.
GlaxoSmithKline temporarily closed a North Carolina factory after testing at a cooling tower found bacteria that causes deadly Legionnaire's disease.
Chart analyst John Kosar believes a pullback in biotechnology stocks could have broader implications for the overall market.
Employers face a set of complex, and potentially expensive, regulations under Obamacare.
Coca-Cola is backing a new "science-based" solution to obesity: To maintain a healthy weight, get more exercise and worry less about cutting calories.
Biotech stocks tumbled last week, and one technician says the industry is approaching a technical breakdown.
Josh Brown is selling one of his top holdings in favor of a health-care name for the CNBC "Halftime Report" Portfolio.
More than 150 million doses of flu vaccine are expected to be shipped this year.
Comedian Jon Stewart took to “The Daily Show’s” desk for the last time, yet he didn’t leave without giving one charity a gift they’d never forget.
Estimates of annual spending on PCSK9 drugs are as high as $150 billion, but drugmakers expect much lower.
Britain's competition watchdog alleged that U.S. drugmaker Pfizer and Flynn Pharma had breached competition law.
A slowdown in the Chinese economy hasn’t deterred pharmaceutical giant Novo Nordisk from expanding its local sales efforts.
Watch the founder of Sproutel pitch his start-up to a panel of experts on CNBC.
Discount retail chain CVS will no longer include Pfizer's Viagra in its list of drug insurance benefits, CNBC confirmed on Wednesday.
Despite a $6,600 per-person, per-year cap on out-of-pocket health costs, Obamacare might not be doing enough, reports USA Today.
For health insurers, government health programs have become an increasingly important part of their business.
Get the best of CNBC in your inbox